Iradimed Corp
IRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.12B
Close$
$55.77
36.5% downside
Current Fair Value
36.5% downsideOvervalued by 36.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.12 Billion |
|---|---|
| Enterprise Value | $1.07 Billion |
| Dividend Yield | $1.27 (1.45%) |
| Earnings per Share | $1.77 |
| Beta | 0.91 |
| Outstanding Shares | 12,784,000 |
Return
| Return on Equity | 22.66% |
|---|---|
| Return on Assets | 20.05% |
| Return on Invested Capital | 26.91% |
Valuation & Multiples
| P/E Ratio | 48.27 |
|---|---|
| PEG | -501.3 |
| Price to Sales | 14.65 |
| Price to Book Ratio | 12.55 |
| Enterprise Value to Revenue | 12.36 |
| Enterprise Value to EBIT | 37.49 |
| Enterprise Value to Net Income | 46 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$20.35 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.52
Average shareholder expectationRevenue Estimate
$23.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.2222▲ 45.85% |
|---|---|
| Total Calls | 13,500▼ 56.31% |
| Total Puts | 16,500▼ 30.08% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 69.35%▲ 9.39% |
|---|---|
| Total Invested | $765.84M▲ 4.31% |
| Investors Holding | 217▼ 15.00% |
ESG Score
No data
About Iradimed Corp
CEO: Roger Susi